ClinicalTrials.gg
RecruitingNCT07755748GSearch-SRIUpdated Sep 9, 2026

Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Incentives

An interventional study of $5 gift card and $100 monthly drawing in Screening, sponsored by University of California, San Francisco. Recruiting at 2 sites in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Screening

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Feb 2026, registered Aug 2026).
  • Started Feb 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
2,000
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

This is a randomized trial to assess whether offering a financial incentive will improve the response rate to a telephone survey. Three incentive approaches will be compared: a $5 gift card, entry into a monthly $100 drawing, or no incentive.

Read the detailed description

This is a sub-trial nested within a larger randomized trial called GSEARCH. The parent trial evaluates whether telemedicine glaucoma screening is more effective for detecting undiagnosed glaucoma cases compared with education alone or delayed intervention, with the final outcomes assessed via a follow-up telephone surveys at 3 months and 12 months. In this sub-study, we will assess whether adding an incentive improves the survey response completion rate. Participants enrolled in the parent GSEARCH trial will be eligible. Participants will be randomized to one of three incentive approaches, offered by telephone at the time of the follow-up survey ($5 gift card, entry into a monthly $100 drawing, or no incentive). The primary outcome will be completion of the telephone survey.

02

Conditions studied

  • Screening

Browse trials for

Keywords

  • Screening
  • Response rate
  • incentive
  • glaucoma
03

In context

Glaucoma

1,419 studies on the registry are indexed under Glaucoma; 223 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 61 across 964 interventional studies indexed under Glaucoma.

Browse Glaucoma studies →

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,169 studies on the registry; 372 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 202 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Participating in GSEARCH trial

Exclusion criteria

Exclusion Criteria:

- Patients without a valid phone number

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,000 participants (estimated)

Study arms

  • Experimental
    $5 gift card

    Other: $5 gift card

  • Active comparator
    $100 monthly drawing

    Other: $100 monthly drawing

  • No intervention
    No incentive

    No incentive is offered for participation in the 3-month survey call.

Interventions

  • Other$5 gift card

    A $5 gift card is offered as an incentive to participation in the 3-month survey call.

  • Other$100 monthly drawing

    Entry into monthly drawing for $100 gift card is offered as an incentive to participation in the 3-month survey call.

06

What researchers measure

Primary outcomes

  1. Survey completion

    Time frame: One month after the outreach call is completed

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — treatment arm, age, gender, survey completion

Time frame: After publication of the primary papers.

Access criteria: Researchers interested in accessing data from this project will submit requests to the investigators following instructions available at the repository. The study's co-PIs will approve requests with clear research questions and processes in place to ensure secure storage of images.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07755748
Responsible party
Sponsor
First posted
Aug 10, 2026
Start date
Feb 1, 2026
Primary completion
Jan 31, 2029 (estimated)
Completion
Sep 30, 2029 (estimated)
Last update
Sep 9, 2026

Study contacts

Dionna Wittberg, MPH
Contact
dionna.wittberg@ucsf.edu
13306083016
Jeremy D Keenan, MD MPH
Contact
jeremy.keenan@ucsf.edu
Jeremy D Keenan, MD MPH
principal investigator · University of California, San Francisco
Yvonne Ou, MD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion